• Home
• News
• About Us
• Contact

Search

Tag Cloud

anthrax Strategic National Stockpile Training exercise Bioterror Biomagnetics National Research Council Homeland Security Biodefense lab Army Medical Research Institute antibiotics Emergency preparedness research Bioweapons NIAID smallpox Detection technology CDC TSA Defense Dept IAEM FEMA immunization Ebola Ricin Hendra Plague treaty West Nile Camouflage Paint Marburg antidote weapons destruction Sarin VHF viruses chemical disposal dna technology prevention Robotics Technology research grants tularemia weapons control foot and mouth disease decontamination E. coli Iraq missile defense Bio-Rescue Dengue fever Botulinum toxin antiviral molecular diagnostics Infectious disease

Subscribe to our newsletter

RSS Feed

Positive results announced for Restanza in treatment of inhaled tularemia
by Ted Purlain on December 17, 2009

Positive top-line results have been announced by Advanced Life Sciences Holdings, Inc., for its once-a-day, oral antibiotic Restanza to treat inhaled lethal doses of tularemia.

Autophay-inducing agent shown to neutralize tularemia
by Nick Rees on December 10, 2009

A recent study in the Journal of Biomedical Science has revealed that an autophagy-inducing agent introduced to the bacteria that causes tularemia in humans can eradicate the small-molecule agents that target innate immunity.

Military researcher infected with tularemia at research laboratory
by Nick Rees on December 9, 2009

A military researcher, working at the United States Army Research Institute of Infectious Diseases, has contracted a laboratory-acquired infection of tularemia.

UIC given funds to develop new bioweapon antibiotics
by Nick Rees on December 4, 2009

Four million dollars in stimulus package funds will be given to researchers at the University of Illinois at Chicago to aid in the development of new antibiotics to treat anthrax, tularemia and plague.